Interventional Oncology-Microinvasive Therapy (SIP), Department of Radiology, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
Eur Radiol. 2021 Sep;31(9):6489-6499. doi: 10.1007/s00330-020-07579-x. Epub 2021 Jan 14.
To retrospectively assess the periablational 3D safety margin in patients with colorectal liver metastases (CRLM) referred for stereotactic radiofrequency ablation (RFA) and to evaluate its influence on local treatment success.
Forty-five patients (31 males; mean age 64.5 [range 31-87 years]) with 76 CRLM were treated with stereotactic RFA and retrospectively analyzed. Image fusion of pre- and post-interventional contrast-enhanced CT scans using a non-rigid registration software enabled a retrospective assessment of the percentage of predetermined periablational 3D safety margin and CRLM successfully ablated. Periablational safety zones (1-10 mm) and percentage of periablational zone ablated were calculated, analyzed, and compared with subsequent tumor growth to determine an optimal safety margin predictive of local treatment success.
Mean overall follow-up was 36.1 ± 18.5 months. Nine of 76 CRLMs (11.8%) developed local tumor progression (LTP) with mean time to LTP of 18.3 ± 11.9 months. Overall 1-, 2-, and 3-year cumulative LTP-free survival rates were 98.7%, 90.6%, and 88.6%, respectively. The periablational safety margin assessment proved to be the only independent predictor (p < 0.001) of LTP for all calculated safety margins. The smallest safety margin 100% ablated displaying no LTP was 3 mm, and at least 90% of a 6-mm circumscribed 3D safety margin was required to achieve complete ablation.
Volumetric assessment of the periablational safety margin can be used as an intraprocedural tool to evaluate local treatment success in patients with CRLM referred to stereotactic RFA. Ablations achieving 100% 3D safety margin of 3 mm and at least 90% 3D safety margin of 6 mm can predict treatment success.
• Volumetric assessment of the periablational safety margin can be used as an intraprocedural tool to evaluate local treatment success following thermal ablation of colorectal liver metastases. • Ablations with 100% 3D periablational safety margin of 3 mm and ablations with at least 90% 3D safety margin of 6 mm can be considered indications of treatment success. • Image fusion of pre- and post-interventional CT scans with the software used in this study is feasible and could represent a useful tool in daily clinical practice.
回顾性评估接受立体定向射频消融(RFA)治疗的结直肠癌肝转移(CRLM)患者的围消融区 3D 安全边界,并评估其对局部治疗成功的影响。
对 45 例(31 例男性;平均年龄 64.5[31-87 岁])76 个 CRLM 患者进行立体定向 RFA 治疗,并进行回顾性分析。使用非刚性配准软件对术前和术后增强 CT 扫描进行图像融合,以回顾性评估预定的围消融区 3D 安全边界百分比和成功消融的 CRLM。计算、分析围消融安全区(1-10mm)和围消融区消融百分比,并与后续肿瘤生长进行比较,以确定预测局部治疗成功的最佳安全边界。
76 个 CRLM 中有 9 个(11.8%)发生局部肿瘤进展(LTP),LTP 的平均时间为 18.3±11.9 个月。总体 1、2、3 年无 LTP 生存率分别为 98.7%、90.6%和 88.6%。围消融安全边界评估是所有计算安全边界中唯一的 LTP 独立预测因子(p<0.001)。显示无 LTP 的最小消融边界 100%切除为 3mm,需要至少 6mm 边界的 90%的环周 3D 安全边界才能实现完全消融。
围消融安全边界的容积评估可作为立体定向 RFA 治疗 CRLM 患者的术中工具,用于评估局部治疗成功。达到 3mm 完全 3D 安全边界和至少 6mm 完全 3D 安全边界的消融可预测治疗成功。
围消融安全边界的容积评估可作为立体定向 RFA 治疗结直肠癌肝转移患者的术中工具,用于评估局部治疗成功。
达到 3mm 完全 3D 安全边界和至少 6mm 完全 3D 安全边界的消融可预测治疗成功。
本研究中使用的术前和术后 CT 扫描图像融合软件是可行的,可能是日常临床实践中的一种有用工具。